All In Biotech

Drug Trial Radar · NCT05408546

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

Evaluation of the Safety and Thrombolytic Effects of Ascending Doses of TS23 in Subjects With Intermediate-Risk (Sub-Massive) Acute Pulmonary Embolism

Last checked: Nov 19, 2026Latest source record: Jul 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

64

Planned (sponsor's estimate)

Start

May 24, 2023

Primary completion

Aug 31, 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Translational Sciences, Inc.Industry
Sponsor type
Industry
First posted
Jun 7, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase II trial of TS23

Conditions

  • Pulmonary Embolism

Interventions

  • TS23Drug

    Monoclonal antibody to a2-antiplasmin

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. RV/LVTime frame: 48 hours after treatment
  2. Safety- BleedingTime frame: within 7 days of treatment

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University Medical Center

    Phoenix, Arizona

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Cottage Hospital

    Santa Barbara, California

  • Wellstar MCG Health Medical Center

    Augusta, Georgia

  • Lifebridge Health

    Baltimore, Maryland

  • Tuft University Hospital

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Wake Forest University/Atrium Health's Carolinas Medical Center

    Winston-Salem, North Carolina

  • Fairview Hospital

    Cleveland, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • Temple University Hospital

    Philadelphia, Pennsylvania

  • Texas Tech University Health Sciences Center at El Paso

    El Paso, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.